Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 11-06-2020 | Practice Area: | Equity Capital Markets |
| Deal Title: | Legend Biotech Corporation Nasdaq Initial Public Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised the underwriters in connection with the USD487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each representing two ordinary shares, which included 2,763,750 ADSs sold pursuant to the underwriters over-allotment option. The ADSs were listed on the Nasdaq Global Select Market under the symbol LEGN.
|
||
| Financial Center: | New York | Value: | 100.01-500.00 |
| Advised Party: | Underwriter | Law Firm | Davis Polk |
| Issuer Jurisdiction- | United States | Listing Jurisdiction- | United States |
| Classification: |
Initial Public Offerings NASDAQ |
Lawyer | Richard D Truesdell Jr |
